Wnt-pathway Activation During the Early Stage of Neurodegeneration in FTDP-17 Mice

Overview

Journal Neurobiol Aging

Publisher Elsevier

Specialties Geriatrics
Neurology
Physiology

Date 2007 Jul 3

PMID 17604878

Citations 11

Authors

Martina Wiedau-Pazos

Eugene Wong

Esther Solomon

Maricela Alarcon

Daniel H Geschwind

Affiliations

Soon will be listed here.

Abstract

Glycogen synthase kinase-3beta (GSK-3beta), a key component of the Wnt signaling pathway, has been recognized as an important tau kinase with a potential pathogenic role in dementia. We have previously shown that GSK-3beta-induced tau-hyperphosphorylation and Wnt-activation enhance tau-induced degeneration in Drosophila. Here, we demonstrate that Wnt-activation occurs prior to 3 months of age in the JNPL3 mouse model of frontotemporal dementia (FTD). We observed that GSK-3beta becomes associated with insoluble tau, concomitant with the increase in the downstream Wnt-pathway component beta-catenin. We demonstrate that this induces downstream Wnt signaling via the activation of nuclear transcription factors associated with beta-catenin, suggesting that Wnt-pathway activation is an early feature of the neurodegenerative process.

Citing Articles

Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling.

Marcogliese P, Dutta D, Sinha Ray S, Dang N, Zuo Z, Wang Y Sci Adv. 2022; 8(3):eabl5613.

PMID: 35044823 PMC: 8769555. DOI: 10.1126/sciadv.abl5613.

Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Vallee A, Lecarpentier Y, Guillevin R, Vallee J Neuromolecular Med. 2018; 20(2):174-204.

PMID: 29572723 DOI: 10.1007/s12017-018-8486-x.

Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease.

Riise J, Plath N, Pakkenberg B, Parachikova A J Neural Transm (Vienna). 2015; 122(9):1303-18.

PMID: 25680440 DOI: 10.1007/s00702-015-1375-7.

Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress.

Moujalled D, James J, Parker S, Lidgerwood G, Duncan C, Meyerowitz J PLoS One. 2013; 8(6):e67433.

PMID: 23840699 PMC: 3694067. DOI: 10.1371/journal.pone.0067433.

Erythropoietin: new directions for the nervous system.

Maiese K, Chong Z, Shang Y, Wang S Int J Mol Sci. 2012; 13(9):11102-11129.

PMID: 23109841 PMC: 3472733. DOI: 10.3390/ijms130911102.

References

Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, van Slegtenhorst M . Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet. 2000; 25(4):402-5. DOI: 10.1038/78078. View

Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K . Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem. 2000; 275(52):41340-9. DOI: 10.1074/jbc.M006219200. View

Lucas J, Hernandez F, Gomez-Ramos P, Moran M, Hen R, Avila J . Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 2001; 20(1-2):27-39. PMC: 140191. DOI: 10.1093/emboj/20.1.27. View

Mattson M . Neuronal death and GSK-3beta: a tau fetish?. Trends Neurosci. 2001; 24(5):255-6. DOI: 10.1016/s0166-2236(00)01838-5. View

Wittmann C, Wszolek M, Shulman J, Salvaterra P, Lewis J, Hutton M . Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 2001; 293(5530):711-4. DOI: 10.1126/science.1062382. View

Lee V, Goedert M, Trojanowski J . Neurodegenerative tauopathies. Annu Rev Neurosci. 2001; 24:1121-59. DOI: 10.1146/annurev.neuro.24.1.1121. View

Moon R, Bowerman B, Boutros M, Perrimon N . The promise and perils of Wnt signaling through beta-catenin. Science. 2002; 296(5573):1644-6. DOI: 10.1126/science.1071549. View

Jackson G, Wiedau-Pazos M, Sang T, Wagle N, Brown C, Massachi S . Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron. 2002; 34(4):509-19. DOI: 10.1016/s0896-6273(02)00706-7. View

Alvarez G, Satrustegui J, Avila J, Bogonez E, Diaz-Nido J . Regulation of tau phosphorylation and protection against beta-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease. Bipolar Disord. 2002; 4(3):153-65. DOI: 10.1034/j.1399-5618.2002.01150.x. View

10.

Sahara N, Lewis J, DeTure M, McGowan E, Dickson D, Hutton M . Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J Neurochem. 2002; 83(6):1498-508. DOI: 10.1046/j.1471-4159.2002.01241.x. View

11.

Hernandez F, Borrell J, Guaza C, Avila J, Lucas J . Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J Neurochem. 2002; 83(6):1529-33. DOI: 10.1046/j.1471-4159.2002.01269.x. View

12.

Lee C, Lau K, Miller C, Shaw P . Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines. Neuroreport. 2003; 14(2):257-60. DOI: 10.1097/00001756-200302100-00020. View

13.

Jope R, Johnson G . The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004; 29(2):95-102. DOI: 10.1016/j.tibs.2003.12.004. View

14.

Mudher A, Shepherd D, Newman T, Mildren P, Jukes J, Squire A . GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry. 2004; 9(5):522-30. DOI: 10.1038/sj.mp.4001483. View

15.

Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller A, Caruso A . Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci. 2004; 24(26):6021-7. PMC: 6729239. DOI: 10.1523/JNEUROSCI.1381-04.2004. View

16.

Selkoe D . The molecular pathology of Alzheimer's disease. Neuron. 1991; 6(4):487-98. DOI: 10.1016/0896-6273(91)90052-2. View

17.

Goedert M, Spillantini M, Cairns N, Crowther R . Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 1992; 8(1):159-68. DOI: 10.1016/0896-6273(92)90117-v. View

18.

Biernat J, Mandelkow E, Schroter C, Steiner B, Berling B, Meyer H . The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 1992; 11(4):1593-7. PMC: 556608. DOI: 10.1002/j.1460-2075.1992.tb05204.x. View

19.

Gustke N, Steiner B, Mandelkow E, Biernat J, Meyer H, Goedert M . The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett. 1992; 307(2):199-205. DOI: 10.1016/0014-5793(92)80767-b. View

20.

Yost C, Torres M, Miller J, Huang E, Kimelman D, Moon R . The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 1996; 10(12):1443-54. DOI: 10.1101/gad.10.12.1443. View